The fungicide mancozeb induces toxic effects on mammalian granulosa cells

https://doi.org/10.1016/j.taap.2012.02.005Get rights and content

Abstract

The ethylene-bis-dithiocarbamate mancozeb is a widely used fungicide with low reported toxicity in mammals. In mice, mancozeb induces embryo apoptosis, affects oocyte meiotic spindle morphology and impairs fertilization rate even when used at very low concentrations. We evaluated the toxic effects of mancozeb on the mouse and human ovarian somatic granulosa cells. We examined parameters such as cell morphology, induction of apoptosis, and p53 expression levels. Mouse granulosa cells exposed to mancozeb underwent a time- and dose-dependent modification of their morphology, and acquired the ability to migrate but not to proliferate. The expression level of p53, in terms of mRNA and protein content, decreased significantly in comparison with unexposed cells, but no change in apoptosis was recorded. Toxic effects could be attributed, at least in part, to the presence of ethylenthiourea (ETU), the main mancozeb catabolite, which was found in culture medium. Human granulosa cells also showed dose-dependent morphological changes and reduced p53 expression levels after exposure to mancozeb. Altogether, these results indicate that mancozeb affects the somatic cells of the mammalian ovarian follicles by inducing a premalignant-like status, and that such damage occurs to the same extent in both mouse and human GC. These results further substantiate the concept that mancozeb should be regarded as a reproductive toxicant.

Graphical abstract

Highlights

► The fungicide mancozeb affects oocyte spindle morphology and fertilization rate. ► We investigated the toxic effects of mancozeb on mouse and human granulosa cells. ► Granulosa cells modify their morphology and expression level of p53. ► Mancozeb induces a premalignant-like status in exposed cells.

Introduction

Mancozeb is a metal ethylene-bis-dithiocarbamate fungicide used to protect many fruits (e.g. apples, citrus), vegetables, (including tomatoes, beans, celery, carrots, onions, ginseng) and field crops against a large spectrum of fungal diseases (EPA 2/92). Occupational exposure to mancozeb occurs in manufacturing or formulating facilities, during field application or by contact with treated foliage or crops. Food intake represents the main source of contamination for the general population. Mancozeb has low acute toxicity in mammals and is rapidly excreted from the body (48–96 h) via urine. Its main catabolite is ethylenthiourea (ETU). In 1988, The World Health Organization (WHO, 1988) estimated that exposure to mancozeb and ETU was 0.01–1 μg/kg b.w./day for the general population. Small quantities of ETU have been detected in tomatoes, potatoes, wine and tobacco, thus suggesting that the population can be chronically exposed to mancozeb starting from childhood. Despite its capacity to induce thyroid and hepatic cancers in rodents (Chhabra et al., 1992), ETU has been degraded from being a group 2B to a group 3 chemical by IARC (2001).

Mancozeb is considered a multipotent carcinogen in laboratory animals (Belpoggi et al., 2002, Cecconi et al., 2007) with evidence for some genotoxic effects (Cecconi et al., 2007). Moreover, mancozeb exposure determines a reduction in T(4) levels in female rats, and may therefore adversely affect the developing brain (Axelstad et al., 2011). In humans, a moderate association between mancozeb exposure and neural tube defects but not thyroid cancer has been reported (Nordby et al., 2005). A recent study reported mancozeb-induced neoplastic potential in human skin in vitro and in mouse skin in vivo (Tyagi et al., 2011). In vitro experiments show that the fungicide mainly targets mitochondrial enzymes (Domico et al., 2006, Leiphon and Picklo, 2007), and that in rat fibroblasts it stimulates the formation of reactive oxygen species (Calviello et al., 2006).

As for reproductive toxicity in general, it is difficult to ascertain whether the adverse effects observed in laboratory animals exposed to pesticides are due to alterations of the gonad-hypothalamic axis, to damages occurring in specific cells of the reproductive organ, or both. In this respect, the use of isolated mouse oocytes provides information about the subtle effects of many pesticides on the acquisition of germ cell developmental capacity (Can and Albertini, 1997, Pocar et al., 2003). Moreover, mancozeb impairs female reproductive performance, with toxic effects becoming already evident at very low concentrations (≤ 1 μg/ml) (Cecconi et al., 2007). Indeed, mouse oocytes exposed to such concentrations (0.01–1 μg/ml) during in vitro maturation showed dose-dependent alterations of meiotic spindle structure and reduction of the fertilization rate in vivo and in vitro (Rossi et al., 2006a, Rossi et al., 2006b). These results are in agreement with a previous report by Greenlee et al. (2004) demonstrating mouse blastomere apoptosis in embryos exposed to 0.003 μg/ml mancozeb. Very little data, however, are available concerning fungicide toxicity on somatic ovarian cells, and in particular on granulosa cells (GC) (Cecconi et al., 2007). These are somatic cells of the mammalian ovary that interact with germ cells from development throughout adult life by forming, together with the oocyte, a functional and metabolic system that ensures the correct development of the whole follicle (Zuccotti et al., 2011). GC can undergo neoplastic transformation thus giving rise to about 5% of all ovarian cancers (Schumer and Cannistra, 2003). GC can thus be used as a model system to test for toxic effects, especially in terms of transformation potential by exogenous substances.

Here we show the effects of mancozeb exposure on GC obtained from laboratory mice and from women undergoing assisted reproduction procedures by evaluating morphology, acquisition of migratory and proliferative features, induction of apoptosis, as well as expression levels of p53.

Section snippets

Chemicals

All chemicals were purchased from Sigma Chemical Company (St. Louis, MO, USA) unless otherwise indicated. Pregnant mare serum gonadotropin (PMSG; Folligon) was purchased from Intervet Italia (Milan, Italy). Mancozeb (> 99% pure) was purchased from AccuStandard, Inc. (New Haven, CT, USA). Reagents for RT and real time PCR, Actinomycin D were purchased from Life Technologies (Carlsbad, CA, USA); Alexa fluor 488- and 594-phalloidin from Invitrogen, Brilliant SYBR Green QPCR master mix from

Effects of mancozeb on the cortical cytoskeleton of mouse GC

To evaluate the effect of mancozeb on cell morphology, mouse GC were cultured for 1, 24 and 36 h in the presence of increasing concentrations of the fungicide (0.001–1 μg/ml), and observed after immunofluorescence staining of cortical actin. At all tested concentrations, GC incubated for 1 h with mancozeb did not show morphological changes compared with untreated control cells (not shown). By contrast, a 24 h-treatment with 0.1 and 1 μg/ml induced cell reshaping and changes in the actin cortical

Discussion

Here we show that the fungicide mancozeb induces a reorganization of the actin cytoskeleton, the acquisition of migratory capacity and a significant decrease of p53 expression levels in mouse GC. These effects are produced by exposure of cells to low doses of fungicide (0.01–1 μg/ml), selected in the range of concentrations that have been shown to induce oocyte meiotic spindle anomalies and impairment of fertilization rate (Rossi et al., 2006a, Rossi et al., 2006b). At the same concentrations,

Summary and conclusions

Our findings demonstrate for the first time that the largely used fungicide mancozeb can negatively affect the function and morphology of mammalian GC even at very low concentrations. The fact that both mouse and human GC were responsive, while supporting our observations, also suggests that at least concerning the reproductive system, the mouse is a reliable model for investigating the toxic effect of mancozeb. The idea that mancozeb may affect human reproduction is also supported by the

Conflict of interest statement

The authors do not have any conflict of interest to disclose.

Acknowledgments

The authors thank Dr. Minoia for ETU quantification. The project was supported by grant from Istituto Superiore di Sanità (CROV/4) and by a generous donation from Cartiera Lucchese (Lucart Group) to S.C.

References (37)

  • A. Alexandrova et al.

    Changes in p53 expression in mouse fibroblasts can modify motility and extracellular matrix organization

    Oncogene

    (2000)
  • M. Axelstad et al.

    Exposure to the widely used fungicide mancozeb causes thyroid hormone disruption in rat dams but no behavioral effects in the offspring

    Toxicol. Sci.

    (2011)
  • M. Baldassarre et al.

    Dynamin participates in focal extracellular matrix degradation by invasive cells

    Mol. Biol. Cell

    (2003)
  • F. Belpoggi et al.

    Results of long-term experimental studies on the carcinogenicity of ethylene-bis-dithiocarbamate (mancozeb) in rats

    Ann. N. Y. Acad. Sci.

    (2002)
  • G.M. Calvert et al.

    Case report: three farmworkers who gave birth to infants with birth defects closely grouped in time and place—Florida and North Carolina, 2004–2005

    Environ. Health Perspect.

    (2007)
  • A. Can et al.

    Stage specific effects of carbendazim (MBC) on meiotic cell cycle progression in mouse oocytes

    Mol. Reprod. Dev.

    (1997)
  • S. Cecconi et al.

    The effects of the endocrine disruptors dithiocarbamates on the mammalian ovary with particular regard to mancozeb

    Curr. Pharm. Des.

    (2007)
  • C. Colosio et al.

    Immunomodulatory effects of occupational exposure to mancozeb

    Arch. Environ. Health

    (1996)
  • Cited by (69)

    • In vitro and in vivo impairment of embryo implantation by commonly used fungicide Mancozeb

      2020, Biochemical and Biophysical Research Communications
      Citation Excerpt :

      Various studies have already been conducted to investigate the effects of several EDCs on endometrial receptivity and embryo implantation [15], but there is limited data on the effects in humans or animals. A few studies have shown that Mancozeb has anti-implantation effects in murine models and can potentially mimic estrogen activity [8]. However, the exact modes of action of Mancozeb on endometrial receptivity, embryo implantation or on general fertility are not fully understood.

    View all citing articles on Scopus
    1

    Equal contribution.

    View full text